As part of our integrated product development services, we provide clinical trial material across small molecule applications for early and late phase clinical trials.
Clinical trial material (CTM) is manufactured for early and late phase clinical trials across oral, parenteral or inhaled applications.
- Drug substances – intermediates, drug substances based on a full range of chemistry including HPAPI and ADC payloads
- Drug-product intermediates – micronized compounds, spray-dried compounds or dispersions, hot-melt extrudates
- Finished drug products – immediate and modified release tablets, encapsulated multiparticulates or powder-based formulations
Small-scale processing is in place to provide CTM for non-GMP feasibility studies and cGMP development and clinical trial studies. Launch and commercial-scale production is also in place to support late-phase clinical supply and commercialization of drug substance, intermediates and/or finished drug products. Rapid development, scale-up and commercialization is facilitated with this phase-appropriate scale and the option for integrated services.